
A study of 2755 adults from the MESA cohort found a strong link between the Systemic Immune-Inflammation Index (SII) and metabolic syndrome (MetS). Higher SII scores were associated with increased risks of hyperglycemia and elevated blood pressure. These findings highlight the potential role of SII as a biomarker for MetS risk assessment in middle-aged and older adults.
Like
Save
Share